Platelet‐activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome
Open Access
- 1 January 2000
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 9 (3-4) , 197-200
Abstract
Sepsis syndrome (SS) is associated with depressed PAF acetylhydrolase, the enzyme responsible for the degradation of platelet activating factor. PAF acetylhydrolase is in a large part produced by macrophages, whose inadequate activation with haemophagocytosis is frequent in patients with SS.Keywords
This publication has 13 references indexed in Scilit:
- Cellular Source(s) of Platelet-Activating-Factor Acetylhydrolase Activity in PlasmaBiochemical and Biophysical Research Communications, 1999
- In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase responseAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1999
- Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.Journal of Clinical Investigation, 1994
- Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsisCritical Care Medicine, 1994
- Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction.1994
- Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: The ODIN modelIntensive Care Medicine, 1993
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Human Macrophages Secrete Platelet-Activating Factor AcetylhydrolaseChest, 1991
- Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor.1989
- APACHE II: a severity of disease classification system.1985